Skip to main content
. 2021 Jun 1;5(8):bvab100. doi: 10.1210/jendso/bvab100

Table 1.

Endocrine toxicity and baseline characteristics

Overall (N = 551) No endocrine toxicity (N = 453) Endocrine toxicity (N = 98)
Factor N Statistics N Statistics N Statistics P-value
Age 551 67.4 ± 13.3 453 67.8 ± 13.5 98 65.7 ± 12.0 0.16a
Gender 551 453 98 0.37c
 Male 359 (65.2) 299 (66.0) 60 (61.2)
 Female 192 (34.8) 154 (34.0) 38 (38.8)
BMI 551 26.5 ± 6.1 453 26.4 ± 5.9 98 27.4 ± 6.9 0.15b
Race 547 450 97 0.086c
 White 493 (90.1) 402 (89.3) 91 (93.8)
 Black 31 (5.7) 30 (6.7) 1 (1.03)
 Other 23 (4.2) 18 (4.0) 5 (5.2)
Cancer type treated
 Breast 551 8 (1.5) 453 6 (1.3) 98 2 (2.0) 0.64d
 Prostate 551 0(0.00) 453 0(0.00) 98 0(0.00) N/A
 Bladder 551 47 (8.5) 453 37 (8.2) 98 10 (10.2) 0.51c
 Renal cell carcinoma 551 68 (12.3) 453 54 (11.9) 98 14 (14.3) 0.52c
 Colon 551 2 (0.36) 453 2 (0.44) 98 0 (0.00) 0.99d
 Pancreatic 551 0(0.00) 453 0(0.00) 98 0(0.00) N/A
 Esophageal 551 2 (0.36) 453 2 (0.44) 98 0 (0.00) 0.99d
 Gastric 551 0(0.00) 453 0(0.00) 98 0(0.00) N/A
 Brain 551 4 (0.73) 453 4 (0.88) 98 0 (0.00) 0.99d
 Melanoma 551 96 (17.4) 453 66 (14.6) 98 30 (30.6) <0.001 c
 Small cell lung cancer 551 18 (3.3) 453 17 (3.8) 98 1 (1.02) 0.22d
 Nonsmall cell lung cancer 551 246 (44.6) 453 212 (46.8) 98 34 (34.7) 0.029 c
 Sarcoma 551 0(0.00) 453 0(0.00) 98 0(0.00) N/A
 Thyroid cancer 551 0(0.00) 453 0(0.00) 98 0(0.00) N/A
 Testicular 551 1 (0.18) 453 1 (0.22) 98 0 (0.00) 0.99d
 Others (detail) 551 27 (4.9) 453 24 (5.3) 98 3 (3.1) 0.45d
 Lymphoma 551 18 (3.3) 453 16 (3.5) 98 2 (2.0) 0.75d
 Leukemia 551 1 (0.18) 453 0 (0.00) 98 1 (1.02) 0.18d
 Ovarian 551 9 (1.6) 453 8 (1.8) 98 1 (1.02) 0.99d
 Oropharyngeal carcinoma 551 10 (1.8) 453 9 (2.0) 98 1 (1.02) 0.99d

Statistics presented as mean ± SD or N (%).

Abbreviations: BMI, body mass index; N/A, not applicable.

a t-test.

bSatterthwaite t-test.

cPearson’s chi-square test.

dFisher’s exact test.